CD8A and neoplasm: An in vivo experimental model found that MDSCs produce ROS and peroxynitrite to induce modification of TCR and CD8 molecules, resulting in CD8+ T cells losing the ability to bind to pMHC complexes and inducing nonresponsiveness in tumour-specific CD8+ T cells in the peripheral blood (169).